GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dongkoo Bio&Pharma Co Ltd (XKRX:006620) » Definitions » Cyclically Adjusted PS Ratio

Dongkoo Bio&Pharma Co (XKRX:006620) Cyclically Adjusted PS Ratio : 1.05 (As of Jun. 05, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Dongkoo Bio&Pharma Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Dongkoo Bio&Pharma Co's current share price is ₩5830.00. Dongkoo Bio&Pharma Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 was ₩5,528.13. Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio for today is 1.05.

The historical rank and industry rank for Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:006620' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.88   Med: 0.9   Max: 1.05
Current: 1.05

During the past 10 years, Dongkoo Bio&Pharma Co's highest Cyclically Adjusted PS Ratio was 1.05. The lowest was 0.88. And the median was 0.90.

XKRX:006620's Cyclically Adjusted PS Ratio is ranked better than
70.73% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs XKRX:006620: 1.05

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dongkoo Bio&Pharma Co's adjusted revenue per share data of for the fiscal year that ended in Dec24 was ₩9,184.777. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩5,528.13 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dongkoo Bio&Pharma Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dongkoo Bio&Pharma Co Cyclically Adjusted PS Ratio Chart

Dongkoo Bio&Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.87

Dongkoo Bio&Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.87 -

Competitive Comparison of Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio falls into.


;
;

Dongkoo Bio&Pharma Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=5830.00/5528.13
=1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dongkoo Bio&Pharma Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Dongkoo Bio&Pharma Co's adjusted Revenue per Share data for the fiscal year that ended in Dec24 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=9184.777/121.1352*121.1352
=9,184.777

Current CPI (Dec24) = 121.1352.

Dongkoo Bio&Pharma Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201512 3,663.302 100.220 4,427.789
201612 3,098.103 101.561 3,695.200
201712 4,502.215 102.991 5,295.393
201812 3,739.918 104.351 4,341.473
201912 4,381.764 105.121 5,049.270
202012 1,639.839 105.765 1,878.140
202112 5,489.676 109.676 6,063.228
202212 7,016.472 115.179 7,379.299
202312 7,815.571 118.837 7,966.710
202412 9,184.777 121.135 9,184.777

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dongkoo Bio&Pharma Co  (XKRX:006620) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Dongkoo Bio&Pharma Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Dongkoo Bio&Pharma Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dongkoo Bio&Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
B-14F, M State Building, 114, Beobwonro, Songpagu, Seoul, KOR, 05836
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

Dongkoo Bio&Pharma Co Headlines

No Headlines